Copyright
©2014 Baishideng Publishing Group Co.
World J Hepatol. Apr 27, 2014; 6(4): 178-187
Published online Apr 27, 2014. doi: 10.4254/wjh.v6.i4.178
Published online Apr 27, 2014. doi: 10.4254/wjh.v6.i4.178
Ref. | UC case group (No) | Centre | End point (No) | Matched controls | Colectomy rate | Is PSC a risk factor? |
Broomé et al[45] | Dys (17) | Hudding, Sweden | PSC (5) | Yes | 0% | Yes |
D’Haens et al[46] | Dys (29) | Chicago, United States | Cholestasis/PSC (10) | Yes | 0% | Yes |
Broomé et al[47] | PSC (40) | Hudding, Sweden | CRC/Dys (15) | Yes | 30% | Yes |
Brentnall et al[48] | PSC (20) | Seattle, United States | Dys (9) | No | 0% | Yes |
Leidenius et al[49] | PSC (45) | Helsinki, Finland | CRC/Dys (13) | Yes | 29% | Yes |
Marchesa et al[50] | PSC (27) | Clevelan, United States | CRC (4)/Dys (14) | Yes | All postop | Yes |
Shetty et al[51] | PSC (132) | Clevelan, United States | CRC (17)/Dys (16) | No | 0% | Yes |
Loftus et al[52] | PSC (143) | Mayo Clinic, United States | CRC (8) | No | 37% | No |
Nuako et al[53] | CRC (171) | Mayo Clinic, United States | PSC (30) | Yes | 14% | No |
- Citation: Tsaitas C, Semertzidou A, Sinakos E. Update on inflammatory bowel disease in patients with primary sclerosing cholangitis. World J Hepatol 2014; 6(4): 178-187
- URL: https://www.wjgnet.com/1948-5182/full/v6/i4/178.htm
- DOI: https://dx.doi.org/10.4254/wjh.v6.i4.178